Status:
UNKNOWN
Early-initiated High Flow Oxygen Therapy vs Conventional Oxygen Therapy Among Patients With ARDS in the Course of SARS-CoV2 Pneumonia.
Lead Sponsor:
Pomeranian Medical University Szczecin
Conditions:
Corona Virus Infection
ARDS Due to Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of the study is to compare two methods of oxygen therapy in patients with acute respiratory distress syndrome in the course of SARS-CoV2 pneumonia. The initial method of oxygen supply during c...
Eligibility Criteria
Inclusion
- The diagnosis of a current SARS-CoV2 infection (confirmed RT-PCR test or antigen test \[allowed in Poland, with sensitivity ≥90 and specificity ≥97\]);
- Hospitalization in the Oxygen Sector of the Temporary Hospital in Szczecin;
- Pneumonia during SARS-CoV2 infection;
- ARDS (PaO 2 / FiO 2 ratio ≤300);
- Oxygen flow 8-12 l / min on mask with reservoir and ≤ 60 mmHg paO2 and / or SpO2 \< 92%;
- TNo current indications for treatment in the ICU;
- Permisson of the patient.
Exclusion
- Probable lack of cooperation with patient;
- Severe Disease disease, eg generalized neoplastic disease;
- Concomitant pulmonary diseases (eg, fibrosis lungs);
- Respiratory acidosis - pH \<7.3 with pCO2\> 50 mmHg;
- Disturbances of consciousness - GCS \< 12;
Key Trial Info
Start Date :
January 18 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05197686
Start Date
January 18 2022
End Date
December 31 2022
Last Update
January 19 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oxygen Therapy Sector of Temporary Hospital
Szczecin, West Pomeranian Voivodeship, Poland, 71-004